Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

Would the Trump administration's recently proposed drug pricing reforms hurt the biotech sector more than pharma? Seeking ...

Unlike Trump's first term, his proposed "most favored nation" policy, tying U.S. drug prices to the lowest prices paid by ...

Donald Trump has signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines ...

Trump told a press conference that the government would impose tariffs if the prices in the U.S. did not match those in other ...

Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international ...

Health policy experts said it is still unclear how much prices will go down, which medicines will be impacted and whether the ...

An executive order the president signed Monday could reduce prices, but some warn it could backfire and raise costs.

U.S. President Donald Trump holds an executive order on prescription drug pricing next to U.S. Health and Human Services (HHS ...

President Donald Trump is attempting to slash drug prices for Americans by more closely aligning their costs to lower prices paid abroad, renewing and expanding upon a failed push from his first term.

The order is a blow to the pharmaceutical industry, which is already bracing for Trump’s planned tariffs on prescription ...